Motus GI Holdings Inc (MOTS)
0.1056
+0.01
(+14.16%)
USD |
OTCM |
May 17, 15:33
Motus GI Holdings SG&A Expense (Quarterly): 1.689M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.689M |
| September 30, 2023 | 1.739M |
| June 30, 2023 | 1.975M |
| March 31, 2023 | 2.787M |
| December 31, 2022 | 2.315M |
| September 30, 2022 | 3.327M |
| June 30, 2022 | 3.297M |
| March 31, 2022 | 3.097M |
| December 31, 2021 | 3.05M |
| September 30, 2021 | 3.04M |
| June 30, 2021 | 3.14M |
| March 31, 2021 | 3.12M |
| December 31, 2020 | 2.708M |
| September 30, 2020 | 2.664M |
| June 30, 2020 | 2.947M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.775M |
| December 31, 2019 | 3.732M |
| September 30, 2019 | 3.188M |
| June 30, 2019 | 3.52M |
| March 31, 2019 | 3.954M |
| December 31, 2018 | 3.893M |
| September 30, 2018 | 3.36M |
| June 30, 2018 | 2.73M |
| March 31, 2018 | 2.874M |
| December 31, 2017 | 2.192M |
| September 30, 2017 | 3.028M |
| June 30, 2017 | 1.384M |
| March 31, 2017 | 2.093M |
| December 31, 2016 | 0.997M |
| September 30, 2016 | 0.759M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.689M
Minimum
Dec 2023
4.775M
Maximum
Mar 2020
2.953M
Average
3.05M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 5.878M |
| Retractable Technologies Inc | 4.158M |
| Xtant Medical Holdings Inc | 20.24M |
| Asensus Surgical Inc | 8.016M |
| Catheter Precision Inc | 2.656M |